Fora Capital, LLC Protagonist Therapeutics, Inc Transaction History

Fora Capital, LLC

  • $791 Million
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021
SELL
$12.95 - $49.69 $35,366 - $135,703
-2,731 Closed
0 $0
Q2 2021

Aug 16, 2021
BUY
$25.57 - $44.88 $69,831 - $122,567
2,731 New
2,731 $123 Million
Q3 2020

Nov 13, 2020
SELL
$15.19 - $22.4 $171,464 - $252,851
-11,288 Closed
0 $0
Q2 2020

Aug 14, 2020
BUY
$6.19 - $18.84 $69,872 - $212,665
11,288 New
11,288 $199 Million

Others Institutions Holding PTGX

# of Institutions
212
Shares Held
59.1M
Call Options Held
19K
Put Options Held
107K
View Full List

About Protagonist Therapeutics, Inc

PTGX Quotes by TradingView
  • Ticker PTGX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 49,084,100
  • Market Cap $2.25B
  • Description
  • Protagonist Therapeutics, Inc., a biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to address hematology and blood disorders, and inflammatory and immunomodulatory diseases. It is developing rusfertide (PTG-300), an injectable hepcidin mimetic that is in Phase II clinical trials for the treatment of patients with...
More about PTGX
Track This Portfolio

Track Fora Capital, LLC Portfolio

Follow Fora Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fora Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fora Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email